Rory J. McCrimmon

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010

Shona Livingstone, Daniel L. Levin, Helen C. Looker et al. · JAMA · 2015 · 613 citations

Social Sciences, Demography, Population Health Sciences +12

Frequency of Thyroid Dysfunction in Diabetic Patients: Value of Annual Screening

Petros Perros, Rory J. McCrimmon, G. Shaw et al. · Diabetic Medicine · 1995 · 445 citations

Medicine, Endocrinology, Diabetology +13

Synaptic Glutamate Release by Ventromedial Hypothalamic Neurons Is Part of the Neurocircuitry that Prevents Hypoglycemia

Qingchun Tong, Chianping Ye, Rory J. McCrimmon et al. · Cell Metabolism · 2007 · 407 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14